Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases

por Wijsenbeek, Marlies S., Brusselle, Guy G.
Publicado 2022

The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?

por Sgalla, Giacomo, Wijsenbeek, Marlies S., Richeldi, Luca
Publicado 2022

Role of the internet of medical things in care for patients with interstitial lung disease

por Nakshbandi, Gizal, Moor, Catharina C., Wijsenbeek, Marlies S.
Publicado 2023

Managing Fatigue in Patients With Interstitial Lung Disease

por Kahlmann, Vivienne, Moor, Catharina C., Wijsenbeek, Marlies S.
Publicado 2020

Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis

por Wijsenbeek, Marlies S., Grutters, Jan C., Wuyts, Wim A.
Publicado 2015

Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis

por Moor, Catharina C., Gür-Demirel, Yasmin, Wijsenbeek, Marlies S.
Publicado 2019

Editorial: Interstitial Lung Disease Around the World

por Wijsenbeek, Marlies, Lee, Joyce S., Udwadia, Zarir, Kreuter, Michael
Publicado 2022

The flare of care for rare: per aspera ad astra for rare lung diseases!

por Wijsenbeek, Marlies, Humbert, Marc, Wagner, Thomas, Kreuter, Michael
Publicado 2023

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis

por Moor, Catharina C., Heukels, Peter, Kool, Mirjam, Wijsenbeek, Marlies S.
Publicado 2017

Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population

por Kahlmann, Vivienne, Moor, Catharina C, Veltkamp, Marcel, Wijsenbeek, Marlies S
Publicado 2021

Exhaled breath analysis in interstitial lung disease

por van der Sar, Iris G., Wijsenbeek, Marlies S., Moor, Catharina C.
Publicado 2023

Comprehensive Care for Patients with Sarcoidosis

por Moor, Catharina C., Kahlmann, Vivienne, Culver, Daniel A., Wijsenbeek, Marlies S.
Publicado 2020

The world of rare interstitial lung diseases

por Buschulte, Katharina, Cottin, Vincent, Wijsenbeek, Marlies, Kreuter, Michael, Diesler, Rémi
Publicado 2023

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

por Kreuter, Michael, Bonella, Francesco, Wijsenbeek, Marlies, Maher, Toby M., Spagnolo, Paolo
Publicado 2015

Feasibility of online home spirometry in systemic sclerosis–associated interstitial lung disease: a pilot study

por Moor, Catharina C, van Leuven, Sander I, Wijsenbeek, Marlies S, Vonk, Madelon C
Publicado 2020

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis

por Glassberg, Marilyn K., Wijsenbeek, Marlies S., Gilberg, Frank, Petzinger, Ute, Kirchgaessler, Klaus-Uwe, Albera, Carlo
Publicado 2019

The use of online visual analogue scales in idiopathic pulmonary fibrosis

por Moor, Catharina C., Mostard, Remy L.M., Grutters, Jan C., Bresser, Paul, Wijsenbeek, Marlies S.
Publicado 2022

Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials

por Noth, Imre, Wijsenbeek, Marlies, Kolb, Martin, Bonella, Francesco, Moros, Lizette, Wachtlin, Daniel, Corte, Tamera J.
Publicado 2019

Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era

por Nakshbandi, Gizal, Moor, Catharina C., Johannson, Kerri A., Maher, Toby M., Kreuter, Michael, Wijsenbeek, Marlies S.
Publicado 2021

Educational aspects of rare and orphan lung diseases

por Alfaro, Tiago M., Wijsenbeek, Marlies S., Powell, Pippa, Stolz, Daiana, Hurst, John R., Kreuter, Michael, Moor, Catharina C.
Publicado 2021